BioCentury This Week: East-West Summit Highlights Part 2

news
Written By Lara Wilson

In a special edition of the BioCentury This Week podcast, Immune-Onc Therapeutics Inc. founder and CEO Charlene Liao discusses how pipeline prioritization and understanding high investor expectations can help companies thrive in today’s difficult financing environment. Listen and learn more here.

Lara Wilson
Previous

Here are six major breakthroughs achieved by Bay Area women-led biotechs
Next

Annual BayHelix awards highlight China’s maturing life sciences sector